Empresa
Sobre Nosotros
Nuestro Equipo
Descubrimientos
Programas
Publicaciones
Seleccionadas
Todas
EN
Contacto
Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth
Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth
Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation
Growth hormone upregulates the pro-tumorigenic galectin 1 in mouse liver
High intratumoural galectin-1 expression predicts adverse outcome in ALK- ALCL and CD30+ PTCL-NOS
Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression
An adipose tissue galectin controls endothelial cell function via preferential recognition of 3-fucosylated glycans
Glioblastomas exploit truncated O – linked glycans for local and distant immune modulation via the macrophage galactose-type lectin
Publisher Correction: Multiple concomitant mechanisms contribute to low platelet count in patients with immune thrombocytopenia
Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits
Single-cell profiling reveals an endothelium-mediated immunomodulatory pathway in the eye choroid
